1
Clinical Trials associated with RO-7823653 / Not yet recruitingPhase 1 A Phase I, Multicenter, Open-Label, Multiple-Ascending Dose Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 Administered by Intravitreal Injection as Monotherapy and in Combination With Faricimab in Patients With Diabetic Macular Edema
The purpose of this study is to evaluate the safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of multiple doses of RO7823653 in participants with DME, administered by intravitreal (IVT) injection as monotherapy and co-administered with faricimab.
100 Clinical Results associated with RO-7823653
100 Translational Medicine associated with RO-7823653
100 Patents (Medical) associated with RO-7823653
100 Deals associated with RO-7823653